Ipravent 15ml Respirator

The usual starting dose of ipratropium bromide HFA inhalation aerosol is two inhalations four times a day. Ipratropium bromide HFA inhalation aerosol is a solution aerosol that does not require shaking. However, as with any other metered-dose inhaler, some coordination is required between actuating the canister and inhaling the medication.

Directions from the U.S. FDA-approved label for Ipratropium Bromide — your doctor or pharmacist may advise differently.

Ipratropium bromide HFA inhalation aerosol is contraindicated in the following conditions., Hypersensitivity to ipratropium bromide or other ipratropium bromide HFA inhalation aerosol components, Hypersensitivity to atropine or any of its derivatives, Hypersensitivity to ipratropium bromide or other ipratropium bromide HFA inhalation aerosol components, Hypersensitivity to atropine or any of its derivatives

Excerpt from the U.S. FDA-approved label for Ipratropium Bromide. Talk to a pharmacist or doctor before use.

Not indicated for the initial treatment of acute episodes of bronchospasm where rescue therapy is required for rapid response, Hypersensitivity reactions including anaphylaxis: Discontinue ipratropium bromide HFA inhalation aerosol at once and consider alternative treatments, Paradoxical bronchospasm: Discontinue ipratropium bromide HFA inhalation aerosol and consider other treatments if paradoxical bronchospasm occurs, Ocular effects: Use with caution in patients with narrow-angle glaucoma and instruct patients to consult a physician immediately if signs or symptoms of narrow-angle glaucoma develop…

Warnings and precautions excerpt from the U.S. FDA-approved label for Ipratropium Bromide — not a complete list. Talk to a pharmacist or doctor before use.

The following adverse reactions are described, or described in greater detail, in other sections: Hypersensitivity Reactions, Including Anaphylaxis, Paradoxical Bronchospasm, Ocular Effects, Urinary Retention Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may…

Excerpt from the U.S. FDA-approved label for Ipratropium Bromide — not a complete list. Talk to a pharmacist or doctor about side effects.

6 brands · 1 maker in the NepalDoc catalog — see the full Ipratropium Bromide guide →

Storage Store at 20°C to 25°C (68°F to 77°F); Keep out of reach of children.

Storage information from the U.S. FDA-approved label for Ipratropium Bromide.